Vivani Medical Inc (VANI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.49+7.19%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · VANI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | — | — | — | — | 0.5 | 0.6 | 3.4 | 3.4 | 6.9 | 8.0 | 4.0 | 8.9 |
| Total Revenues | — | — | — | — | — | — | — | — | — | — | 4.0 | 8.9 |
| Cost of Revenues | — | — | — | — | — | 0.1 | 0.5 | 2.2 | 4.9 | — | — | 5.3 |
| Gross Profit | — | — | — | — | — | 0.1 | 0.5 | 1.2 | 2.0 | 2.8 | (6.1) | 3.7 |
| Operating Expenses & Income | ||||||||||||
| R&D Expenses | 18.0 | 18.1 | 15.7 | 17.0 | 14.2 | 11.0 | 4.8 | 13.1 | 10.0 | 7.9 | 5.3 | 3.0 |
| Other Operating Expenses, Total | — | — | — | 1.3 | 7.4 | — | — | — | — | — | — | — |
| Operating Income | (27.2) | (27.6) | (24.7) | (27.0) | (21.2) | (13.3) | (14.9) | (34.0) | (35.2) | (28.6) | (33.2) | (20.0) |
| Earnings from Continuing Operations | ||||||||||||
| Asset Writedown | — | — | — | — | — | 0.7 | 0.7 | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (26.6) | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | — | — | — |
| Net Income | ||||||||||||
| Net Income | 26.9 | (26.6) | (23.5) | 25.7 | (13.9) | (12.8) | (14.9) | (33.6) | (35.1) | (28.5) | (33.2) | (20.0) |
| Per Share | ||||||||||||
| Basic EPS | 0.31 | (0.43) | (0.43) | (0.50) | — | — | — | — | — | — | — | — |
| Diluted EPS | 0.31 | (0.43) | (0.43) | (0.50) | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 87.1 | 62.4 | 0.1 | 0.1 | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 87.1 | 62.4 | 0.1 | 0.1 | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | (27.1) | (24.3) | (26.6) | (20.8) | (13.0) | (14.7) | (33.6) | (34.8) | (28.1) | (32.8) | (19.7) |
| EBIT | (27.2) | (27.6) | (24.7) | (27.0) | (21.2) | (13.3) | (14.9) | (34.0) | (35.2) | (28.6) | (33.2) | (20.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.